Low pathogenic Avian Influenza Virus (LPAIV) – H9N2 subtype and Newcastle Disease Virus (NDV) inactivated vaccine.
Formulation:
Emulsion for injection.
Composition:
Each 0.2 ml dose contains:
• Inactivated antigen of low pathogenic avian influenza virus, subtype H9N2 GI like viruses (KSA2/H9.4.1.2 and KSA5/H9.4.1.3) ≥ 7 log2 HI.U1
• Inactivated antigen of Newcastle disease virus, Genotype II (La Sota) and Genotype VII.1.1 (RYD)≥ 50 PD50*
The concentrations are expressed by the antibody titer obtained during the potency test
One unit (U) corresponding to an antibody titer of 1.
1 HI: Hemagglutination Inhibition.
* PD50: Protective dose in 50% of the tested animals
Indication:
Active immunization to reduce clinical signs and mortality of chickens against infection with low pathogenic avian influenza virus (H9N2)and Newcastle disease virus (NDV).
Onset of immunity: 2 – 3 weeks after vaccination.
Duration of immunity: 4- 6 weeks after vaccination.
Pack sizes:
250 ml and 500 ml